LEXXW — Lexaria Bioscience Corp · rev $705.9K

Lexaria Bioscience Corp (LEXXW) common stock listed on US.

Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.

Use this LEXXW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LEXXW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LEXXW SEC filings page. Lician reads the product cache first so this HTML stays unique to Lexaria Bioscience Corp even when a live quote feed is slow.

Lexaria Bioscience Corp latest statements (FY2025)

Latest cached year on this hub. Full LEXXW income, balance, and cash tables.

  • Revenue$705.9K
  • Net Income-$11.9M
  • Total Assets$4.2M
  • Total Debt$0
  • Free Cash Flow$0